Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
Year: 2020
Type: review
Source: Clinical Rheumatology
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: COVID-19 pandemic, SARS-CoV-2, rheumatic manifestations, cytokine storm, secondary hemophagocytic lymphohistiocytosis, ACE2, ACE inhibitors, ibuprofen, hydroxychloroquine, chloroquine, lopinavir/ritonavir, remdesivir, favipiravir, glucocorticoids, immunosuppressive therapy, disease-modifying drugs, tocilizumab
Open Access status: bronze
OpenAlex ID: W3015542196
